All News

Approximately 1 in 5 patients in a study were misdiagnosed with multiple sclerosis before being referred to treatment centers.

Top news of the day from across the health care landscape.

Drug-drug interactions are considered on a daily basis, but it may also be important to consider food-drug interactions as this may also impact overall efficacy and safety of certain medications.

Amgen’s ABP 501 (Amjevita) shows similar efficacy to the reference adalimumab (Humira) in treating rheumatoid arthritis and supported approval of the biosimilar by the FDA.

The Next-Generation Pharmacist® Awards program recognizes pioneers, innovators and future leaders in the pharmacy industry. Pharmacist nominations represent chain, independent and specialty pharmacies; government and academic institutions; long-term care facilities; and health-system pharmacists.

With this approval, patients who have never been treated have the option of a 2-drug regimen in a single tablet, as opposed to the standard-of-care 3-drug regimen for HIV.

With this approval, patients with HIV who have never been treated have the option of a 2-drug regimen in a single tablet.

Efficiency means doing things right, while effectiveness means doing the right things.

Adenosine deaminase is an ultra-rare and inherited disorder that is detrimental to the immune system and causes severe combined immune deficiency.

Top news of the day from across the health care landscape.

Sun Pharma's gemcitabine in sodium chloride injection is the first and only chemotherapy product in a premixed, ready-to-infuse formulation, which eliminates steps in the complex chemotherapy preparation process.

Why is this woman taking a drug used to treat prostate problems?

Physicians who used an electronic health record system found to have a better cognitive workload and performance.

If these products were confused, it coul result in someone ingesting "could result in ingesting toxic amounts of liquid nicotine. Likewise, nicotine exposures of these sorts are extremely problematic and could be fatal for children."

Enfortumab vedotin is being investigated for the treatment of locally advanced or metastatic urothelial cancer following both platinum-containing chemotherapy and a PD-1 or PD-L1 inhibitor.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

The CDC's Tips From Former Smokers campaign has new powerful messages to encourage individuals to quit smoking.

For the study, the researchers assessed whether a slow-release, long-acting, implantable naltrexone could improve outcomes for patients with HIV and opioid addiction.

The matching of optimized technologies and novel approaches has provided investigators with a framework to assess and understand neurologic conditions.

The announcement follows months of investigating impurities found in ARBs.

The indication’s expansion for palbociclib to include male patients is based upon data from postmarketing reports and electronic health records showing that the safety profile for men treated with the drug is consistent with the safety profile in women treated with this medication.

By participating in the P&T Competition, student pharmacists gain experience in gathering and critically analyzing scientific, clinical, and economic evidence in a systematic and rigorous fashion, according to the foundation.

Specialty pharmacy can benefit from having definitive a center of excellence model that caters to respective therapies and disease states.

An implantable form of naltrexone was more effective in improving HIV outcomes in patients compared with oral naltrexone.

Top news of the day from across the health care landscape.

Rizaport is an oral film formulation of rizatriptan benzoate, the active drug in Maxalt, for patients with migraine who experience dysphagia or migraine-related nausea.

The hearing will take place May 13, 2019 at the agency’s headquarters in Silver Spring, Maryland.